Aradigm Corp (NASDAQ:ARDM)

CAPS Rating: No stars

A pharmaceutical company focused on the development and commercialization of a portfolio of drugs delivered by inhalation for the treatment of severe respiratory diseases by pulmonologists.

Caps

This ticker is not currently Ratable.

Add Stock to CAPS Watchlist

All Players

4 Outperform
4 Underperform
 

All-Star Players

0 Outperform
4 Underperform
 

Wall Street

2 Outperform
0 Underperform
 

Top ARDM Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

zzlangerhans (99.82)
Submitted February 19, 2015

Aradigm stock has been chugging along in a narrow range with low volumes after some initial volatility following the 40:1 reverse split last year. I have a hard time getting excited about the company and their inhalational quinolone for… More

SmartAce (99.96)
Submitted January 26, 2017

This hasn't helped my bull get any sleep at all. In fact, the closer I get to him with the bulldozer, the more agitated he gets.

ARDM VS S&P 500 (SPY)

Recent Community Commentary

Read the most recent pitches from players about ARDM.

No one has written a Pitch for ARDM stock yet. Tell us why you think ARDM will outperform or underperform against the market.

Leaderboard

Find the members with the highest scoring picks in ARDM.

Score Leader

SmartAce

SmartAce (99.96) Score: +170.10

The Score Leader is the player with the highest score across all their picks in ARDM.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
zzlangerhans 99.82 10/16/2017 Underperform 1Y $5.00 -73.80% +7.52% +81.32 0 Comment
80brown 99.96 3/13/2018 Underperform 5Y $1.28 +2.42% -1.72% -4.14 0 Comment
srkenne264 99.22 3/14/2018 Underperform 5Y $1.24 +5.65% -0.69% -6.33 0 Comment
gpierson128 97.95 2/27/2018 Underperform 5Y $1.24 +5.65% -1.33% -6.98 0 Comment
chushogi 68.01 12/21/2016 Outperform 5Y $1.77 -25.99% +21.28% -47.27 0 Comment
EvilEmpire 29.83 11/8/2016 Outperform 5Y $4.71 -72.19% +29.01% -101.20 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackPZK < 20 9/5/2014 Outperform NS $9.10 -85.60% +37.08% -122.69 0 Comment
trackmerriman 69.79 9/5/2014 Outperform NS $9.10 -85.60% +37.08% -122.69 0 Comment

Featured Broker Partners


Advertisement